C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
260/605.4, 260/6
C07C 87/24 (1980.01) C07C 93/10 (1980.01)
Patent
CA 1155459
ABSTRACT OF THE DISCLOSURE New decaprenylamines having the general formula: Image (I) wherein R1 represents a hydrogen atom, a decaprenyl group, a lower alkyl group or a hydroxy-lower alkyl group, and R2 represents a lower alkyl or alkenyl group optionally sub- stituted with at least one hydroxy, amino or alkylamino group, or a cycloalkyl group, and the pharmaceutically acceptable acid addition salts thereof, are prepared by (a) converting decaprenol of the formula: (II) Image into a corresponding halide or sulfonic acid ester which is thereafter reacted with a primary or secondary amino compound having the general formula: Image (III) wherein R1 and R2 have the aforesaid meanings, in the pre- sence or absence of a base, to obtain the desired decaprenyl- amine of the formula (I), or (b) oxidizing decaprenol to a corresponding aldehyde which is then condensed with a primary amino compound having the general formula: H2N - R2 (III') wherein R2 has the aforesaid meanings, to form a correspond- ing imino compound which in turn is reduced to obtain a decaprenylamine of the formula (I) in which R1 is hydrogen and R2 has the aforesaid meanings. When a pharmaceutically acceptable acid addition salt is desired, the decaprenylamine of the formula (I) thus obtained is further reacted with a pharmaceutically acceptable acid to provide the desired salt. The decaprenylamines of the formula (I) are useful for controlling virus infection of vertebrate animals.
365239
Komatsu Yasuhiro
Koyama Hiroyasu
Kubota Reiko
Tahara Yoshiyuki
Takahashi Toshihiro
Nisshin Flour Milling Co. Ltd.
Swabey Ogilvy Renault
LandOfFree
Decaprenylamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Decaprenylamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Decaprenylamine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-406966